Biochemical markers in bronchial carcinoma

McKenzie, Craig R. M.; Evans, Imogen M. A.; Hillyard, C. J.; Hill, Patricia A.; Carter, S; Tan, M K; MacIntyre, I.

doi:10.1038/bjc.1977.252

Cited by 32 publications

(13 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The incidence of raised plasma calcitonin in this study is lower than that for some other studies (McKenzie et al, 1977;Gropp et al, 1980;Hansen et al, 1980) …”

contrasting

confidence: 81%

Plasma calcitonin in small cell lung cancer: prognostic significance

Ap¹,

Carter²,

Ellison³

et al. 1983

Br J Cancer

Self Cite

View full text Add to dashboard Cite

“…The incidence of raised plasma calcitonin in this study is lower than that for some other studies (McKenzie et al, 1977;Gropp et al, 1980;Hansen et al, 1980) …”

contrasting

confidence: 81%

Plasma calcitonin in small cell lung cancer: prognostic significance

Ap¹,

Carter²,

Ellison³

et al. 1983

Br J Cancer

Self Cite

View full text Add to dashboard Cite

“…The highest incidence of CEA elevations was in patients with lung adenocarcinomas. This fact was also observed by McKenzie et al [7] and in our own laboratory. Although immune complexes have been observed in bronchogenic carcinomas, they have been found in many patients with be nign lung disease.…”

supporting

confidence: 89%

14. Lung Cancer

Schwartz¹

1987

Tumor Biol

View full text Add to dashboard Cite

“…Calcitonin was elevated in 59% of 425 SCLC patients [151,[175][176][177][178][179][180]. Elevated concentrations are rare in other types of lung cancer [177,181].…”

Section: Calcitoninmentioning

confidence: 99%

Serum tumour markers in lung cancer: history, biology and clinical applications

Ferrigno¹,

Buccheri²,

Biggi³

1994

Eur Respir J

102

View full text Add to dashboard Cite

S Se er ru um m t tu um mo ou ur r m ma ar rk ke er rs s i in n l lu un ng g c ca an nc ce er r: : h hi is st to or ry y, , b bi io ol lo og gy y a an nd d c cl li in ni ic ca al l a ap pp pl li ic ca at ti io on ns s Several tumour markers have been studied in lung cancer. Unfortunately, none of these appear to be sufficiently sensitive and specific to be reliable for screening and diagnostic purposes. However, there is a body of evidence which proves that at least some of these substances may be useful in the evaluation of the course and prognosis of the disease.This review presents data concerning the most studied and interesting tumour markers in lung cancer.

show abstract

Biochemical markers in bronchial carcinoma

Cited by 32 publications

References 15 publications

Plasma calcitonin in small cell lung cancer: prognostic significance

Plasma calcitonin in small cell lung cancer: prognostic significance

14. Lung Cancer

Serum tumour markers in lung cancer: history, biology and clinical applications

Contact Info

Product

Resources

About